219 related articles for article (PubMed ID: 31376931)
1. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo.
Liu X; Zhu S; Cui J; Shao H; Zhang W; Yang H; Xu Y; Geng D; Yu L
Acta Biomater; 2014 Nov; 10(11):4912-4918. PubMed ID: 25078426
[TBL] [Abstract][Full Text] [Related]
3. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-κB ligand in vivo.
Geng T; Sun S; Chen X; Wang B; Guo H; Zhang S; Jin Q
Mol Med Rep; 2018 Mar; 17(3):3829-3836. PubMed ID: 29257329
[TBL] [Abstract][Full Text] [Related]
5. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
Ihn HJ; Kim K; Cho HS; Park EK
Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of COX-2 inhibitor on titanium-particle-induced inflammatory osteolysis via the down-regulation of RANK/RANKL.
Geng D; Mao H; Wang J; Zhu X; Huang C; Chen L; Yang H; Xu Y
Acta Biomater; 2011 Aug; 7(8):3216-21. PubMed ID: 21601661
[TBL] [Abstract][Full Text] [Related]
7. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
[TBL] [Abstract][Full Text] [Related]
10. Gö6983 attenuates titanium particle-induced osteolysis and RANKL mediated osteoclastogenesis through the suppression of NFκB/JNK/p38 pathways.
Feng W; Li J; Liao S; Ma S; Li F; Zhong C; Li G; Wei Y; Huang H; Wei Q; Yao J; Liu Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):62-70. PubMed ID: 29856998
[TBL] [Abstract][Full Text] [Related]
11. 5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio.
Wang Y; Liu H; Wu J; Liao Y; Lu D; Dong F; Li H; Zhang Z; Lian Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):629-634. PubMed ID: 32736684
[TBL] [Abstract][Full Text] [Related]
12. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
[TBL] [Abstract][Full Text] [Related]
13. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
[TBL] [Abstract][Full Text] [Related]
14. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
Niu J; Bi F; Tian Q; Tian K
J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
[TBL] [Abstract][Full Text] [Related]
15. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo.
Chen S; Jin G; Huang KM; Ma JJ; Wang Q; Ma Y; Tang XZ; Zhou ZJ; Hu ZJ; Wang JY; Qin A; Fan SW
Sci Rep; 2015 Aug; 5():12853. PubMed ID: 26238331
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
[TBL] [Abstract][Full Text] [Related]
17. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
[TBL] [Abstract][Full Text] [Related]
18. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N
Front Immunol; 2020; 11():1720. PubMed ID: 32849609
[TBL] [Abstract][Full Text] [Related]
19. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhai ZJ; Li HW; Liu GW; Qu XH; Tian B; Yan W; Lin Z; Tang TT; Qin A; Dai KR
Br J Pharmacol; 2014 Feb; 171(3):663-75. PubMed ID: 24125472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]